DAILY UPDATE
 December 20, 2021
Dear Valued Reader,

It seems a little cruel to talk up the obesity epidemic when we're smack-dab in the middle of the "overeating" part of the calendar... but Dave Lashmet at Stansberry is teasing a coming approval for an amazingly effective obesity drug as likely to create the "biggest drug in the world", maybe generating more than a trillion dollars in sales.  So what's the story, and what's the stock?  Just click below to...


He found Apple at $1.49... Oracle at $0.51... Amazon at $46.

Marketwatch called him "The Advisor Who Recommended Google Before Anyone Else."

Now, investing legend Louis Navellier is revealing his Top 11 Stocks to Buy for 2022.
 

Click here to receive your free new report.


Advertisement

Miss anything last week?  Let's catch you up...

We started with a new Whitney Tilson ad campaign for something he calls "Netstake", a company bringing Netflix magic to gambling... just click here for that one.

Then it was on to another "Miracle Mineral" teased -- this time it's phosphate, and we gotta find more or we'll all starve!  But wait, the Outsider Club found some, hiding under a lake!  Where?  Just click here for our take, and the Thinkolator solution.

I re-posted our solution to Carr's "Ultimate $10 Growth Stock" pitch, since we got more questions about that this week.

And I shared a quickie solution for a Michael Robinson tease about the Metaverse -- he's hinting at two stocks and one cryptocurrency, and the Thinkolator is on the case.

For the Friday File last week I shared some big-picture thoughts on inflation, which drifts into some updates on dividend growth updates from companies we own and a buy of one of those that just boosted the dividend this week. I also entered into a renewed hedging position, so I'll detail that... just click below if you missed the Friday email...



Stock Gumshoe | travis@stockgumshoe.com | www.stockgumshoe.com
351 Pleasant St., Suite B #205, Northampton, MA 01060
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

Having trouble viewing this email? Read the web version.

You may unsubscribe if you no longer wish to receive our emails. We have no wish to email people who don't want to receive these messages. Please note that unsubscribing applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.